The Era of Compounded GLP-1 Drugs Is Over. What Now? https://www.medscape.com/viewarticle/era-compounded-glp-1-drugs-over-what-now-2025a10008kq Now that the US Food and Drug Administration has removed both tirzepatide and semaglutide from its Drug Shortages List, the widespread compounding of these drugs is ending. Tirzepatide’s deadline has already passed, while physicians and pharmacies have until April 22 for semaglutide. An estimated […]
Filed under: General Problems | Leave a Comment »